Articles tagged with Adrenergic Receptor Signaling
The study identified amino acids crucial for ligand selectivity in two groups of receptors, β-adrenergic and D1-like dopamine receptors. By modifying these amino acids, the researchers made each receptor prefer its native ligand. The findings suggest that regions outside of the primary binding site also play a role in selectivity.
Scientists found that tumor-promoting fibroblasts attract nerve fibers through a vicious cycle of signaling and neurotransmitter release. This cycle promotes pre-cancerous growth and pulls in more nerve fibers, leading to a self-reinforcing loop. Disrupting this cycle may lead to new therapies for pancreatic cancer.
Researchers at Redoxoma found that mitochondrial potassium channels regulate heat production in brown adipose tissue, a process critical for regulating energy expenditure and promoting metabolic health. Closing the channel is necessary for maximum thermogenesis.
Calmming the brain's immune cells via norepinephrine may prevent or lessen Alzheimer's inflammation and damage. The study highlights a key role of norepinephrine in mitigating early inflammatory changes and neuronal injury.
Researchers at UVA Health System found that a hyperactive nervous system response can worsen C. difficile infections, leading to severe diarrhea, nausea, and colitis. Targeting the alpha 2 adrenergic receptor may provide a new therapeutic target for treating these deadly infections.
Researchers discovered that adrenergic signals from the autonomic nervous system determine whether macrophages multiply and migrate into damaged heart tissue. This communication also plays a crucial role in regenerating heart muscle tissue.
Researchers identified a crucial molecular process involving gene expression in neurons that contributes to early memory loss and Alzheimer's disease. Genetic alterations in mice showed that lack of phosphorylation on beta-2 adrenergic receptors led to poor memory, while PDE inhibitors improved memory function.
Researchers found that clonidine, a common blood pressure medication, can reduce the consolidation of traumatic memories in PTSD patients. By interacting with the adrenergic receptor axis, clonidine interferes with cofilin's ability to form mushroom-shaped dendritic spines, which are essential for memory formation. This suggests that c...
A new gene therapy approach has been developed to boost the expression of the beta-3 adrenergic receptor in heart cells, improving mitochondrial function and preventing or reversing heart failure in a mouse model of aortic stenosis. This could potentially provide new therapeutic options for patients with this condition.
The locus coeruleus region plays a crucial role in regulating learning from reward and punishment, optimizing behavior and mental health. The region integrates sensory inputs and internal cognitive states to precisely exert its influence.
A study found that Vitamin B6 deficiency is associated with social deficits, cognitive impairment, and hyperactivated noradrenergic systems in mice. Supplementing the brain with Vitamin B6 improved these abnormalities, suggesting a potential therapeutic strategy for schizophrenia patients with Vitamin B6 deficiency.
Research suggests that cesarean delivery leads to lower levels of key 'birth signaling hormones', which may influence long-term neurodevelopmental outcomes. The study's findings have significant implications for understanding the potential effects of cesarean delivery on autism and obesity rates.
Studies have revealed that the journey of a nascent protein to become a mature cell surface receptor involves multiple steps and complex interactions with proteins such as C1orf27, HCR1, and GGA3. Understanding these mechanisms is crucial for optimizing hormone and drug use targeting GPCRs.
Researchers at the University of Michigan have discovered a new signaling pathway that can regulate beige fat thermogenesis independently of adrenergic signaling. This discovery opens a new direction for approaching metabolic disorders and could potentially provide a treatment option for patients with catecholamine resistance.
Scientists discovered a key mechanism underlying Alzheimer's pathology, revealing how amyloid-beta oligomers hijack norepinephrine signaling to activate GSK3-beta and hyper-phosphorylate tau protein. This rewiring of the alpha-2A adrenergic receptor may explain the failure of previous clinical trials targeting amyloid protein buildup.
A new experimental treatment for stroke has been shown to reduce brain damage and promote motor recovery in mice. The treatment, which uses adrenergic receptor antagonists, was found to normalize brain fluids and lower potassium levels, leading to improved outcomes in stroke models.
Researchers discovered that fluoxetine, an antidepressant, causes bone loss by increasing epinephrine levels and impairing bone formation. However, co-treating with low-dose beta-blockers may prevent this effect. This finding has significant implications for preventing fractures in peri- and postmenopausal women.
Research at UT Southwestern Medical Center found that beta 1 adrenergic receptors mediate ghrelin release, which prevents hypoglycemia. The study suggests that suppression of ghrelin release by beta blockers may be responsible for low blood sugar levels in children taking these drugs.
Researchers found that norepinephrine enhances the ability of neurons to code for complex sounds by decreasing background noise firing. This mechanism is separate from estradiol's effects and provides new insights into neuromodulator interactions and auditory processing.
Researchers have developed CNiFERs cells to track dopamine signaling, providing a real-time readout of neurochemical activity associated with learning, memory and reward. The study reveals that dopamine release is linked to classical conditioning and anticipatory behavior.
Researchers found a brain-to-body signaling circuit in roundworms that enables weight loss independently of food intake, involving serotonin and octopamine neurotransmitters. The discovery hints at a similar circuit in humans and other mammals, potentially leading to more potent weight-loss therapies combining serotonin and adrenaline.
Scientists at Scripps Research Institute have determined the 3D structure of the human glucagon receptor, a key drug target for type 2 diabetes. The study's findings provide new information on how cells regulate glucose levels and may aid in the development of treatments for glucose-related disorders.
Researchers at Stanford University School of Medicine have found that a formoterol, an asthma medication, strengthens nerve connections in the hippocampus and improves contextual learning in mice with Down syndrome. The study provides initial proof-of-concept for targeting beta-2 adrenergic receptors as a potential treatment strategy.
Researchers at UMass Chan Medical School reveal the molecular mechanism behind the roundworm's escape response, linking two separate actions coordinated by tyramine and its interaction with fast- and slow-acting receptors.
Researchers at Duke University Medical Center discovered a mechanism linking chronic stress to DNA damage. Stress leads to prolonged lowering of p53 levels, which can cause chromosomal irregularities. The study used an adrenaline-like compound in mice and found that degradation of p53 resulted in accumulation of DNA damage.
Signaling receptors recycle at a slower rate and in a more regulated manner than other classes of receptors. The researchers identified unique domains called Actin-Stabilized Sequence-dependent Recycling Tubule (ASSERT) domains that provide a scaffold for the receptors, slowing their release from the endosome.
Researchers have determined the structure of CXCR4, a protein that guides blood-forming stem cells, and its interactions with chemokine ligands. The findings may lead to new drugs for hematopoietic stem cell transplantation and treating HIV infection.
Researchers identified two experimental drugs that harness the fight-or-flight response to restore pumping strength to failing hearts. By targeting a key protein, these compounds slow and halt the progression of heart disease.
Researchers at Stanford University School of Medicine identified a new method for reducing drug side effects by focusing on neglected areas of cell-surface proteins. By analyzing the shape changes in response to drugs, they discovered potential targets for more selective and effective medications.
Researchers at Thomas Jefferson University have discovered a new strategy against heart failure by targeting the adrenal gland. By blocking GRK2, an enzyme that regulates fight or flight hormones, they were able to reduce hormone production and improve heart function.
Researchers at UT Southwestern Medical Center identified the QseC receptor used by a diarrhea-causing strain of E coli to initiate infection. By using phentolamine, an alpha blocker drug, they successfully impeded signaling to the receptor, blocking bacterial infections.
Researchers at Thomas Jefferson University have discovered a potential biomarker, GRK2, that can predict the severity of heart failure. Elevated levels of this enzyme in the blood are associated with more severe heart failure and may help identify patients who would benefit from specific treatments.
Researchers successfully restored heart cell function by inhibiting the ßARK1 enzyme in laboratory-dish experiments using a gene therapy approach. The study's findings suggest that blocking this enzyme could increase signaling and improve heart function in individuals with end-stage heart failure.
Duke University researchers have defined the distribution of alpha-1 adrenergic receptors in human blood vessels, shedding light on potential new treatments for diseases such as high blood pressure and prostate enlargement. The study's findings suggest that aging processes alter receptor expression, making it crucial to develop targete...
Researchers at UNC Chapel Hill discovered molecular changes in nerve cells that may play a role in causalgia, a painful medical syndrome. The study found that nerve fibers affected by injury become supersensitive to norepinephrine, leading to persistent burning pain.
Duke researchers develop a molecular decoy protein that blocks the signaling pathway leading to heart cell growth in response to high blood pressure. The study provides a potential single-drug therapy strategy for treating congestive heart failure.
Research found an association between genetic variations in the serotonin-2A receptor and response to clozapine, a drug targeting serotonin receptors. Further studies support this hypothesis, suggesting that serotonin receptors play a key role in the therapeutic action of antipsychotic drugs.
A new class of drugs may be able to target the leptin loop, a key component in obesity and metabolic disorders. By bypassing this loop, these drugs could potentially provide a new treatment option for individuals struggling with weight-related health issues.